NeuroSearch A/S reports change of employee elected Board member

1/28/2013 5:02 AM EST

NeuroSearch A/S
Company Announcement

NeuroSearch A/S reports change of employee elected Board member

Announcement
28.01.2013



By the end of January 2013, the employee elected Board member Mads P.G.
Korsgaard will resign from the Board of Directors of NeuroSearch A/S (NEUR) due
to the expiration of his employment with the company. 

With effect from 1 February 2013, IT Director Morten Henrik Nielsen will
re-join the Board as employee elected Board member. 

Morten Henrik Nielsen was employed at NeuroSearch in 1989 and was a member of
the Board of Directors for some time in 2012. 


René Schneider
CEO


Contact person
René Schneider, CEO, telephone: +45 4460 8700 or +45 2911 2097



About NeuroSearch
NeuroSearch A/S (NEUR) is listed on NASDAQ OMX Copenhagen A/S. The company’s
product pipeline comprises ordopidine and seridopidine, which have both
completed phase I studies, as well as tesofensine, which has completed phase II
and NS2359 which has completed phase I. 
All drug candidates exert their effect in the central nervous system.